Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vickie Hanrahan
Observed names:
V Hanrahan,
V. HANRAHAN
Institution:
Canterbury Health Laboratories
Observed institutions:
Canterbury Health Laboratories,
University of Otago
OpenAlex ID:
A5083804153
The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression
2003
·
Vickie Hanrahan
, Margaret J Currie
, et al.
·
The Journal of Pathology
·
262
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1α) and the HIF-1α target gene DEC1, but not lymph node metastasis in primary human breast carcinomas
2004
·
M J Currie
, V Hanrahan
, et al.
·
Journal of Clinical Pathology
·
81
PDF
The molecular aetiology of haemophilia A in a New Zealand patient group
2007
·
A. D. LAURIE
, C. R. SHEEN
, et al.
·
Haemophilia
·
23
Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera
2006
·
Peter Ganly
, Vickie Hanrahan
, et al.
·
American Journal of Hematology
·
13
Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient
2005
·
L Chee
, R L Spearing
, et al.
·
Bone Marrow Transplantation
·
8
Haemophilia A, factor VIII intron 22 inversion screening using subcycling-PCR
2006
·
Nicole Kilian
, Vera Pospisil
, et al.
·
Thrombosis and Haemostasis
·
7
Show more works
View as search
Works count:
6
Citation count:
394
H-index:
6
I10-index:
4
Year
Topic
Type